Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03776071
Title A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Denovo Biopharma LLC
Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.